OptimizeRx Corporation (OPRX) NASDAQ
6.40
+0.47(+7.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.40
+0.47(+7.93%)
Currency In USD
| Market Cap | 227.49M |
| Enterprise Value | 230.23M |
| P/E Ratio | 23.27 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.09 |
| Price/Book Ratio | 0.93 |
| Enterprise/Revenue | 1.12 |
| Enterprise/EBITDA | 7.45 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.05 |
| Operating Margin | 0.11 |
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
| Revenue | 109.43M |
| Revenue/Share | 5.86 |
| Gross Profit | 69.27M |
| EBITDA | 16.39M |
| Net Income | 5.13M |
| Diluted EPS | 0.27 |
| Total Cash | 23.37M |
| Total Cash/Share | 1.25 |
| Total Debt | 26.1M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 3.04 |
| Book Value Per Share | 6.87 |
| 52-Week Change | -17.63 |
| 52-Week High | 22.25 |
| 52-Week Low | 5.54 |
| Moving Average 50 Days | 10.13 |
| Moving Average 200 Days | 14.33 |
| Average Volume | 379,040 |
| Shares Outstanding | 18.64M |
| % Held by Institutions | 71.97 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | May 14, 2018 |